PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))

Metabolite details

Identifier

JYWXVFXGOBTFQZ-RHOQSXGDSA-N

InChI Key

JYWXVFXGOBTFQZ-RHOQSXGDSA-N

IUPAC name

[(2R)-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))

INN name

—

Synonym

—

ChEBI

CHEBI:188273

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection

Observed in differential profiles

• Control_vs_AONFH_Stage_III_IV
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h